MoneyWorks4Me

Emmessar Biotech & Nutrition informs about disclosure

18 Sep 2023 Evaluate

In compliance with the provision of SEBI Reg 2011, Emmessar Biotech & Nutrition has informed that Mathurakavi Srinivasa Raghavan Ayyangar, Chief Promoters, have acquired 4765 equity shares of the company from September 01 to September 15, 2023, Through open market.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..